Novate (Clobetasol Propionate)

Clobetasol Propionate, the active ingredient in Novate, is a corticosteroid presented as a topical formulation for skin application. It is used to manage inflammatory skin disorders such as psoriasis, eczema, dermatitis, and lichen planus in adult patients.

GNH USA supplies Novate as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across global markets throughout efficiently. The company adheres to stringent quality standards and regulatory requirements to ensure reliable access for healthcare providers worldwide globally.

Clobetasol Propionate is a high‑potency topical corticosteroid used to treat inflammatory skin conditions. - Psoriasis: Reduces scaling, erythema and plaque thickness. - Eczema: Decreases itching, redness and inflammation. - Dermatitis: Controls acute flare‑ups and relieves irritation. - Lichen planus: Improves lesions and lessens discomfort.

Clobetasol Propionate may cause local and systemic adverse reactions, particularly with prolonged or extensive use.

Common Side Effects: - Skin irritation or burning sensation. - Pruritus or itching at the application site. - Dryness or peeling of the treated skin.

Serious or Rare Side Effects: - Skin atrophy or thinning with long‑term use. - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression, especially when applied over large areas.

When prescribing Clobetasol Propionate, clinicians should consider several safety precautions to minimize risk. - Avoid use on infected or ulcerated skin: risk of systemic absorption and worsening infection. - Limit treatment duration: use only as long as clinically necessary, typically not exceeding 2‑4 weeks. - Do not apply occlusive dressings unless directed: may increase drug penetration. - Use with caution in children: higher surface‑area‑to‑body‑weight ratio raises systemic exposure. - Avoid use on large body surface areas: increases risk of systemic effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Clobetasol Propionate can interact with other medications, affecting its safety or efficacy.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - CYP3A4 inducers (e.g., rifampicin): may reduce local efficacy. - Potent antifungal agents (e.g., ketoconazole): can increase percutaneous absorption.

Moderate Interactions (Monitor Closely): - Topical NSAIDs: may increase local irritation. - Retinoids (topical): heightened risk of skin irritation and atrophy. - Antibiotic ointments: possible alteration of local flora and infection risk.